Patent · US Active

Deuterated compound and medical use thereof

US10759809B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignee

TAIZHOU HUAYUAN MEDICINAL TECH CO. LTD. · CN

Inventors

Bohua Zhong · Beijing, CN
Jianming Wang · Beijing, CN
Jiajun Yang · Beijing, CN

Key dates

Filing date	Jan 26, 2018
Grant date	Sep 1, 2020
Priority date	—
Expiry date	Jan 26, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound represented by formula I and a non-toxic pharmaceutically acceptable salt thereof. In formula (I), R1 is H, CH3 or deuterated methyl (CD3); R2 is CH3 or CH2CH3; R3, R4 and R5 are each independently H or deuterium (D); when R1 is H or CH3, at least one of R3, R4 and R5 is D.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.